Outcomes of Oncoplastic Breast Surgery and Goldilocks Mastectomy at Tufts Medicine
Official title: Understanding Long-Term Outcomes of Oncoplastic Breast Surgery
Run by Tufts Medical Center · NCT07597837 · Data updated 2026-11-12
This study will look at past and future surgical results and patient satisfaction after oncoplastic breast surgery or Goldilocks mastectomy at Tufts Medicine to see how patients fare over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 1500 (estimated) |
| Sponsor | Tufts Medical Center Academic / other |
| Locations | 2 sites (Boston, Massachusetts and 1 other locations) |
| Status | Recruiting |
| Started | February 26, 2026 |
| Main results expected | January 2045 |
| Study ends | January 2045 |
| Registry record updated | May 27, 2026 |
| Trial ID | NCT07597837 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Biological female patients aged 18 or older undergoing oncologic breast surgery with or without reconstruction at Tufts Medicine.
✕Probably not a fit
Patients not undergoing oncologic breast procedures at the participating institutions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational study combining retrospective and prospective chart reviews from 2015 to 2045. It focuses on surgical outcomes for oncoplastic breast procedures and Goldilocks mastectomy, and it collects patient-reported satisfaction using validated surveys. Data will come from Tufts Medical Center and Melrose Wakefield Hospital to characterize safety, effectiveness, and patient experience. The study does not assign treatments but observes real-world practice and outcomes. Results may help inform future care and decision-making for patients considering these procedures.
Why it matters
Potential benefit: If successful, the study could improve understanding of long-term outcomes and satisfaction for oncoplastic and Goldilocks breast procedures.
How similar studies have gone: Prior observational work in breast surgery has shown valuable insights; this study builds on established methods but remains largely observational and longitudinal.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Biological females \>= 18 years old requiring oncologic breast surgery with and without reconstruction at Tufts Medicine. Exclusion Criteria: * Biological females \< 18 years old
Where it's running
-
Tufts Medical Center
Boston, Massachusetts, United States Recruiting -
Melrose Wakefield Hospital
Melrose, Massachusetts, United States Active not recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.